Novel Therapies in Neovascular AMD and DME: Achieving Superior Anatomic Outcomes with Fewer Injections

Podcast

Moderator:

Enrico Borrelli, MD, FEBO
San Raffaele Hospital
Milan, Italy

Enrico Borrelli, MD, PhD, FEBO is a retina specialist at San Raffaele Hospital in Milan, Italy. His research interests include image analysis and ocular imaging (retinal and choroidal disorders), age-related macular degeneration (AMD), pachychoroid disease, and diabetic retinopathy. He has authored or co-authored over 200 articles in peer reviewed international journals. His work has been recognized with several international awards and grants including the Ophthalmologica Euretina Award and Global Ophthalmology Award Program (GOAP).



Improving Vascular Stability in DME

Featuring:

Roger A. Goldberg, MD, MBA
Retina specialist, Bay Area Retina Associates
California, USA

Dr. Roger A. Goldberg is board certified by the American Board of Ophthalmology and is an active member of the American Society of Retinal Specialists, the Retina Society, and the American Academy of Ophthalmology. Dr. Goldberg has published numerous research manuscripts and book chapters, including first-author publications in The New England Journal of Medicine, Ophthalmology, JAMA Ophthalmology, and American Journal of Ophthalmology. He has been an investigator in over 30 clinical trials for age-related macular degeneration, retinal vein occlusion, and diabetic retinopathy, among others.


In this episode, Dr. Enrico Borrelli interviews Dr. Roger Goldberg to discuss the enhanced vascular stability observed with novel therapies in diabetic macular edema.




Accelerating Fluid Resolution in DME

Featuring:

Andreas Pollreisz, MD
Medical University of Vienna
Vienna, Austria

Dr. Andreas Pollreisz is a specialist in ophthalmology with a focus on retinal diseases at the Department of Ophthalmology at the Medical University of Vienna (MUV). His clinical interest is in diabetic retinopathy, age-related macular degeneration and vitreoretinal surgery. His research interest lies in retinal imaging with a focus on different optical coherence tomography systems, including OCT- Angiography and adaptive optics assisted instruments. Dr. Pollreisz leads the “Retina Advanced Imaging Study Group“ at the Medical University of Vienna and serves as principal investigator in multicenter clinical trials.


In this episode, Dr. Enrico Borrelli interviews Dr. Andreas Pollreisz to explore advanced therapies that promise enhanced fluid resolution in diabetic macular edema.




Prolonging the Dosing Interval in Neovascular AMD

Featuring:

Dr. Roberto Gallego-Pinazo, MD, PhD
Oftalvist Clinic
Valencia, Spain

Dr. Gallego Pinazo specialized in diagnosis and management of retina diseases through a fellowship at VRM New York under the mentorship of Dr. Lawrence Yannuzzi in 2012. He has published over 200 scientific papers in the field of macular and retinal diseases. Dr Gallego-Pinazo has acted as principal investigator in over 50 clinical trials on treatments for the main causes of blindness derived from retinal diseases, with new drugs, devices, and gene therapy.


Dr. Enrico Borrelli and Dr. Roberto Gallego-Pinazo discuss strategies to extend the frequency of treatment and explore novel agents with greater durability for neovascular age-related macular degeneration.

Related Videos
ARVO 2024: Andrew D. Pucker, OD, PhD on measuring meibomian gland morphology with increased accuracy
 Allen Ho, MD, presented a paper on the 12 month results of a mutation agnostic optogenetic programme for patients with severe vision loss from retinitis pigmentosa
Noel Brennan, MScOptom, PhD, a clinical research fellow at Johnson and Johnson
ARVO 2024: President-elect SriniVas Sadda, MD, speaks with David Hutton of Ophthalmology Times
Elias Kahan, MD, a clinical research fellow and incoming PGY1 resident at NYU
Neda Gioia, OD, sat down to discuss a poster from this year's ARVO meeting held in Seattle, Washington
Eric Donnenfeld, MD, a corneal, cataract and refractive surgeon at Ophthalmic Consultants of Connecticut, discusses his ARVO presentation with Ophthalmology Times
John D Sheppard, MD, MSc, FACs, speaks with David Hutton of Ophthalmology Times
Paul Kayne, PhD, on assessing melanocortin receptors in the ocular space
Osamah Saeedi, MD, MS, at ARVO 2024
© 2024 MJH Life Sciences

All rights reserved.